Reduced lumbar CSF somatostatin in levels in Alzheimer's disease
Paul L. Wood, N.P.V. Nair(Douglas Mental Health University Institute), Serge Gauthier(McGill University), Pierre Étienne(McGill University), Santiago Ramón y Cajal(Universitat Autònoma de Barcelona), Samarthji Lal(Montreal General Hospital)
Cited by 181
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Mild cognitive impairment: a concept in evolution
|Journal of Internal Medicine|2014|1.7k
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
|Nature Neuroscience|1998|1.6k
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
|Nature Medicine|2021|364
The modulatory effects of corticosteroids on cognition: studies in young human populations
|Psychoneuroendocrinology|2002|353